Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action

Lamia Y Haque; Yenny Paola Zuluaga Blanco; Roberto Muga Bustamante; Daniel Fuster Marti

doi:10.1186/s13722-024-00448-8

Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action

Lamia Y Haque, Yenny Paola Zuluaga Blanco, Roberto Muga Bustamante, Daniel Fuster Marti

Department of Medicine

Research output: Contribution to journal › Article › Research › peer-review

5 Citations (Scopus)

Abstract

Alcohol-associated liver disease is currently the leading cause of liver transplantation and liver deaths both in Europe and the United States. Efficacious treatments exist for alcohol use disorder, but they are seldomly prescribed for patients who need them. Besides, the presence of liver cirrhosis can complicate pharmacological treatment choices. In this review, we discuss established and innovative treatment strategies to treat unhealthy alcohol use in patients with alcohol-associated liver disease. We also describe the experience of our own institutions, Hospital Universitari Germans Trias i Pujol in Badalona (Spain) and Yale-New Haven Health and Yale Medicine (Connecticut. United States of America).

Original language	English
Article number	19
Number of pages	11
Journal	Addiction science & clinical practice
Volume	19
Issue number	1
DOIs	https://doi.org/10.1186/s13722-024-00448-8
Publication status	Published - 19 Mar 2024

Keywords

Alcohol use disorder
Alcohol-associated liver disease
Treatment
Addiction medicine
Hepatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s13722-024-00448-8Licence: CC BY

https://ddd.uab.cat/record/293962

Cite this

@article{c395b26954e047c7ba0bf643358ecd5d,

title = "Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action",

abstract = "Alcohol-associated liver disease is currently the leading cause of liver transplantation and liver deaths both in Europe and the United States. Efficacious treatments exist for alcohol use disorder, but they are seldomly prescribed for patients who need them. Besides, the presence of liver cirrhosis can complicate pharmacological treatment choices. In this review, we discuss established and innovative treatment strategies to treat unhealthy alcohol use in patients with alcohol-associated liver disease. We also describe the experience of our own institutions, Hospital Universitari Germans Trias i Pujol in Badalona (Spain) and Yale-New Haven Health and Yale Medicine (Connecticut. United States of America).",

keywords = "Alcohol use disorder, Alcohol-associated liver disease, Treatment, Addiction medicine, Hepatology",

author = "Haque, {Lamia Y} and {Zuluaga Blanco}, {Yenny Paola} and {Muga Bustamante}, Roberto and {Fuster Marti}, Daniel",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = mar,

day = "19",

doi = "10.1186/s13722-024-00448-8",

language = "English",

volume = "19",

journal = "Addiction science & clinical practice",

issn = "1940-0632",

number = "1",

}

TY - JOUR

T1 - Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action

AU - Haque, Lamia Y

AU - Zuluaga Blanco, Yenny Paola

AU - Muga Bustamante, Roberto

AU - Fuster Marti, Daniel

N1 - Publisher Copyright: © The Author(s) 2024.

PY - 2024/3/19

Y1 - 2024/3/19

N2 - Alcohol-associated liver disease is currently the leading cause of liver transplantation and liver deaths both in Europe and the United States. Efficacious treatments exist for alcohol use disorder, but they are seldomly prescribed for patients who need them. Besides, the presence of liver cirrhosis can complicate pharmacological treatment choices. In this review, we discuss established and innovative treatment strategies to treat unhealthy alcohol use in patients with alcohol-associated liver disease. We also describe the experience of our own institutions, Hospital Universitari Germans Trias i Pujol in Badalona (Spain) and Yale-New Haven Health and Yale Medicine (Connecticut. United States of America).

AB - Alcohol-associated liver disease is currently the leading cause of liver transplantation and liver deaths both in Europe and the United States. Efficacious treatments exist for alcohol use disorder, but they are seldomly prescribed for patients who need them. Besides, the presence of liver cirrhosis can complicate pharmacological treatment choices. In this review, we discuss established and innovative treatment strategies to treat unhealthy alcohol use in patients with alcohol-associated liver disease. We also describe the experience of our own institutions, Hospital Universitari Germans Trias i Pujol in Badalona (Spain) and Yale-New Haven Health and Yale Medicine (Connecticut. United States of America).

KW - Alcohol use disorder

KW - Alcohol-associated liver disease

KW - Treatment

KW - Addiction medicine

KW - Hepatology

UR - http://www.scopus.com/inward/record.url?scp=85188131137&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/d5554816-5acb-3fe7-b79a-32c17de2d1df/

U2 - 10.1186/s13722-024-00448-8

DO - 10.1186/s13722-024-00448-8

M3 - Article

C2 - 38504384

SN - 1940-0632

VL - 19

JO - Addiction science & clinical practice

JF - Addiction science & clinical practice

IS - 1

M1 - 19

ER -

Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this